Indian Firm Develops Affordable Cholera Vaccine

Wall Street Journal: Indian Firm Develops Inexpensive Vaccine for Battle With Cholera
“…New Delhi-based Hilleman Laboratories Pvt. — which is backed by Merck & Co. and the Wellcome Trust charity — said Tuesday that it has created an inexpensive [cholera] vaccine that can survive without refrigeration in the far-flung tropical villages where it is most needed…” (McLain, 6/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.